Literature DB >> 8198522

Regulation of aflatoxin B1-metabolizing aldehyde reductase and glutathione S-transferase by chemoprotectors.

L I McLellan1, D J Judah, G E Neal, J D Hayes.   

Abstract

Ingestion of aflatoxin B1 (AFB1) represents a major risk factor in the aetiology of human hepatocellular carcinoma. In the rat, the harmful effects of AFB1 can be prevented by the administration of certain drugs which induce hepatic detoxification enzymes. We have previously shown that treatment of rats with the chemoprotector ethoxyquin (EQ) results in a marked increase in expression of the Alpha-class glutathione S-transferase (GST) Yc2 subunit which has high activity towards AFB1-8,9-epoxide [Hayes, Judah, McLellan, Kerr, Peacock and Neal (1991) Biochem. J. 279, 385-398]. To allow an assessment of whether the increased expression of GST Yc2 represents a general adaptive resistance mechanism to chemical stress, that is invoked by both chemoprotectors and carcinogens, we have examined the effects of EQ, butylated hydroxyanisole (BHA), butylated hydroxytoluene (BHT), phenobarbital (PB), AFB1, 3-methylcholanthrene (3-MC) and clofibrate on the AFB1-glutathione-conjugating activity and the GST subunit levels in rat liver. In addition, the effect of these drugs on the hepatic levels of an aldehyde reductase (AFB1-AR) that metabolizes the cytotoxic dialdehydic form of AFB1 has been studied as this enzyme also appears to be important in chemoprotection. Administration of the antioxidants EQ, BHA or BHT, as well as PB, led to a marked increase in levels of the GST Yc2 subunit in rat liver, and this increase coincided with a substantial rise in the GST activity towards AFB1-8,9-epoxide; neither AFB1, 3-MC nor clofibrate caused induction of Yc2 or any of the GST subunits examined. Among the xenobiotics studied, EQ was found to be the most effective inducing agent for the Yc2 subunit as well as Yc1, Yb1 and Yf. However, PB was equally as effective as EQ in increasing levels of the Ya-type subunits, although it was not found to be as potent an inducer of the other GST subunits, including Yc2. In addition to induction of GST, EQ caused a substantial increase in the hepatic content of AFB1-AR. Both BHA and BHT were also able to induce this enzyme but, by contrast, PB was found to be a poor inducer of AFB1-AR. AFB1, 3-MC and clofibrate were unable to serve as inducers of this reductase. The presence of Alpha-class GST, including the Yc2 subunit, was examined in various rat tissues. Constitutive expression of Yc2 was found in the epididymis at levels comparable with that observed in the liver from EQ-treated rats.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8198522      PMCID: PMC1138132          DOI: 10.1042/bj3000117

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  45 in total

1.  On the protective action of certain polycyclic aromatic hydrocarbons against carcinogenesis by aminoazo dyes and 2-acetylaminofluorene.

Authors:  E C MILLER; J A MILLER; R R BROWN; J C MACDONALD
Journal:  Cancer Res       Date:  1958-05       Impact factor: 12.701

Review 2.  Aflatoxin exposure in human populations: measurements and relationship to cancer.

Authors:  J D Groopman; L G Cain; T W Kensler
Journal:  Crit Rev Toxicol       Date:  1988       Impact factor: 5.635

3.  Purification and characterization of glutathione S-transferases P, S and N. Isolation from rat liver of Yb1 Yn protein, the existence of which was predicted by subunit hybridization in vitro.

Authors:  J D Hayes
Journal:  Biochem J       Date:  1984-12-15       Impact factor: 3.857

4.  Mouse liver glutathione S-transferase isoenzyme activity toward aflatoxin B1-8,9-epoxide and benzo[a]pyrene-7,8-dihydrodiol-9,10-epoxide.

Authors:  H S Ramsdell; D L Eaton
Journal:  Toxicol Appl Pharmacol       Date:  1990-09-01       Impact factor: 4.219

5.  Difference in the effects of phenobarbital and 3-methylcholanthrene treatment on subunit composition of hepatic glutathione S-transferase in male and female rats.

Authors:  T Igarashi; N Irokawa; S Ono; S Ohmori; K Ueno; H Kitagawa; T Satoh
Journal:  Xenobiotica       Date:  1987-02       Impact factor: 1.908

Review 6.  Carcinogenicity and modification of the carcinogenic response by BHA, BHT, and other antioxidants.

Authors:  N Ito; S Fukushima; H Tsuda
Journal:  Crit Rev Toxicol       Date:  1985       Impact factor: 5.635

7.  An ethoxyquin-inducible aldehyde reductase from rat liver that metabolizes aflatoxin B1 defines a subfamily of aldo-keto reductases.

Authors:  E M Ellis; D J Judah; G E Neal; J D Hayes
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-01       Impact factor: 11.205

8.  Regulation of epididymal glutathione S-transferases: effects of orchidectomy and androgen replacement.

Authors:  B Robaire; B F Hales
Journal:  Biol Reprod       Date:  1982-05       Impact factor: 4.285

9.  Regulatory mechanisms of monofunctional and bifunctional anticarcinogenic enzyme inducers in murine liver.

Authors:  H J Prochaska; P Talalay
Journal:  Cancer Res       Date:  1988-09-01       Impact factor: 12.701

10.  A novel aldehyde reductase with activity towards a metabolite of aflatoxin B1 is expressed in rat liver during carcinogenesis and following the administration of an anti-oxidant.

Authors:  D J Judah; J D Hayes; J C Yang; L Y Lian; G C Roberts; P B Farmer; J H Lamb; G E Neal
Journal:  Biochem J       Date:  1993-05-15       Impact factor: 3.857

View more
  7 in total

Review 1.  The aldo-keto reductase superfamily and its role in drug metabolism and detoxification.

Authors:  Oleg A Barski; Srinivas M Tipparaju; Aruni Bhatnagar
Journal:  Drug Metab Rev       Date:  2008       Impact factor: 4.518

2.  Characterization of the rat glutathione S-transferase Yc2 subunit gene, GSTA5: identification of a putative antioxidant-responsive element in the 5'-flanking region of rat GSTA5 that may mediate chemoprotection against aflatoxin B1.

Authors:  D J Pulford; J D Hayes
Journal:  Biochem J       Date:  1996-08-15       Impact factor: 3.857

3.  Determinants of specificity for aflatoxin B1-8,9-epoxide in alpha-class glutathione S-transferases.

Authors:  P D McDonagh; D J Judah; J D Hayes; L Y Lian; G E Neal; C R Wolf; G C Roberts
Journal:  Biochem J       Date:  1999-04-01       Impact factor: 3.857

4.  Generation of a New Model Rat: Nrf2 Knockout Rats Are Sensitive to Aflatoxin B1 Toxicity.

Authors:  Keiko Taguchi; Misaki Takaku; Patricia A Egner; Masanobu Morita; Takehito Kaneko; Tomoji Mashimo; Thomas W Kensler; Masayuki Yamamoto
Journal:  Toxicol Sci       Date:  2016-04-12       Impact factor: 4.849

5.  Effect of graded Nrf2 activation on phase-I and -II drug metabolizing enzymes and transporters in mouse liver.

Authors:  Kai Connie Wu; Julia Yue Cui; Curtis D Klaassen
Journal:  PLoS One       Date:  2012-07-12       Impact factor: 3.240

Review 6.  Dietary modifiers of carcinogenesis.

Authors:  L Kohlmeier; N Simonsen; K Mottus
Journal:  Environ Health Perspect       Date:  1995-11       Impact factor: 9.031

7.  Dealing with aflatoxin B1 dihydrodiol acute effects: Impact of aflatoxin B1-aldehyde reductase enzyme activity in poultry species tolerant to AFB1 toxic effects.

Authors:  Hansen Murcia; Gonzalo J Diaz
Journal:  PLoS One       Date:  2020-06-22       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.